Serum and Saliva MMP-3 in Patients with OLP and Oral SCC
- 1 February 2015
- journal article
- research article
- Published by Jaypee Brothers Medical Publishing in The Journal of Contemporary Dental Practice
- Vol. 16 (2) , 107-111
Abstract
Background: Matrix metalloproteinase-3 (MMP-3) plays a key role in development of cancer. The purpose of this study was to assess MMP-3 in the serum and saliva of patients with oral lichen planus (OLP) and oral squamous cell carcinoma (OSCC).Materials and methods: Thirty patients with OLP (8 reticular and 22 erosive forms), and 20 patients with OSCC (6 in low stage and 14 in advanced stage), were enrolled in this study, conducted at the Cancer Department, Clinic of Oral Medicine, Tehran University of Medical Sciences. The serum and saliva MMP-3 was assayed by ELISA method. Statistical analysis of the Student's t-test, ANOVA and Pearson correlation coefficient was performed. The mean saliva and serum levels of MMP-3 were significantly higher in patients with OSCC compared with OLP.Results: The serum and saliva MMP-3 concentrations increased from reticular form of OLP to erosive form of OLP, and increased further to low stage of OSCC and advanced stage of OSCC. Serum MMP-3 correlated significantly with unstimulated (r = 0.310, p = 0.038) and stimulated (r = 0.365, p < 0.026) saliva MMP-3.Conclusion: Serum and saliva MMP-3 levels appear associated with OLP and OSCC.How to cite this article: Agha-Hosseini F, Mirzaii-Dizgah I, Mahboobi N, Shirazian S, Harirchi I. Serum and Saliva MMP-3 in Patients with OLP and Oral SCC. J Contemp Dent Pract 2015;16(2):107-111.Keywords
This publication has 17 references indexed in Scilit:
- Comparative evaluation of low-level laser and CO2 laser in treatment of patients with oral lichen planusInternational Journal of Oral and Maxillofacial Surgery, 2012
- Tumor and Salivary Matrix Metalloproteinase Levels Are Strong Diagnostic Markers of Oral Squamous Cell CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2011
- Salivary analysis of oral cancer biomarkersBritish Journal of Cancer, 2009
- Efficacy of purslane in the treatment of oral lichen planusPhytotherapy Research, 2009
- MMPs, TIMP‐2, and TGF‐β1 in the cancerization of oral lichen planusHead & Neck, 2008
- Requirement of MMP‐3 in anchorage‐independent growth of oral squamous cell carcinomasJournal of Oral Pathology & Medicine, 2007
- Malignant Oral Tumors in IranJournal of Craniofacial Surgery, 2006
- Expression of matrix metalloproteinases (MMP‐2, MMP‐3, and MMP‐9) and fibronectin in lichen planusJournal of Cutaneous Pathology, 2006
- Matrix metalloproteinase gene expression in oral lichen planus: erosive vs. reticular formsJournal of the European Academy of Dermatology and Venereology, 2006
- Methylene blue‐mediated photodynamic therapy: A possible alternative treatment for oral lichen planusLasers in Surgery and Medicine, 2006